GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Ambar Protein Industries Ltd

Ambar Protein Q2 FY27 Net Profit at Rs. 219.91 Lacs, down 56.95% YoY

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 05 Nov 2026, 04:29 PM IST  ·  BSE ID: 1e62ce1b-6e26-4751-bdd3-35d1930a58fa
View Original BSE Filing (PDF)
💡
In Simple Terms
Ambar Protein Industries' net profit for the second quarter of its financial year 2027 decreased by 56.95% to Rs. 219.91 Lacs.
🤖 AI Summary
  • Ambar Protein Industries reported a net profit of Rs. 219.91 Lacs for Q2 FY27, a 56.95% decrease YoY.
  • Revenue from operations reached Rs. 11,883.82 Lacs for the quarter ended September 30, 2026.
  • Total expenses for Q2 FY27 were Rs. 11,652.66 Lacs, up from Rs. 10,853.05 Lacs in Q2 FY26.
  • Basic Earnings Per Share (EPS) for Q2 FY27 stood at Rs. 3.83, compared to Rs. 6.53 in Q2 FY26.
  • The Board of Directors approved the unaudited financial results for the quarter and half year ended September 30, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
11,883.82 Lacs
4.75
Net Profit (Q2 FY27)
219.91 Lacs
-56.95
Total Expenses (Q2 FY27)
11,652.66 Lacs
7.37
Basic EPS (Q2 FY27)
3.83 Rs.
-41.35
🏢 How This Affects the Company
📈
Business Impact
Revenue from operations increased, suggesting continued business activity in the edible oil segment, which is the company's only reported segment.
💰
Financial Impact
A substantial decline in net profit and EPS indicates pressure on profitability despite higher revenue. This impacts overall earnings and cash generation.
⚠️
Risk Impact
The significant decrease in net profit highlights profitability challenges, potentially increasing financial risk if not addressed in subsequent periods.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, with the decline in net profit impacting overall earnings. Basic EPS reduced from Rs. 6.53 in Q2 FY26 to Rs. 3.83 in Q2 FY27.
🔍
Management Signal
The approval of the unaudited financial results signals management's official reporting of performance for the quarter and half-year ended September 30, 2026.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 results — monitor net profit margin trends and cost management.
Future investor calls — look for management commentary on profitability challenges.
Subsequent balance sheets — examine working capital and cash flow trends.
MEDIUM RISK Significant year-on-year decline in net profit despite revenue growth indicates profitability challenges.
💡 Investor Takeaway
Ambar Protein Industries reported Q2 FY27 net profit of Rs. 219.91 Lacs, representing a 56.95% decrease from Rs. 510.76 Lacs in Q2 FY26. Revenue from operations increased to Rs. 11,883.82 Lacs from Rs. 11,344.84 Lacs during the same period.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from operations increased by 4.75% to Rs. 11,883.82 Lacs in Q2 FY27 from Rs. 11,344.84 Lacs in Q2 FY26.
  • Total Income for Q2 FY27 was Rs. 11,906.19 Lacs, an increase from Rs. 11,363.81 Lacs in Q2 FY26.

⚠️ Concerns

  • Net Profit declined by 56.95% to Rs. 219.91 Lacs in Q2 FY27 compared to Rs. 510.76 Lacs in Q2 FY26.
  • Basic EPS decreased to Rs. 3.83 in Q2 FY27 from Rs. 6.53 in Q2 FY26.
📅 Company Track Record
Ambar Protein Industries reported a Q2 FY27 net profit decline of 56.95% to Rs. 219.91 Lacs, following a similar filing on 2026-11-05 which also highlighted this net profit decline for the same period. This provides context on the company's recent profitability trend.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Ambar Protein Industries' net profit in Q2 FY27?
Ambar Protein Industries reported a net profit of Rs. 219.91 Lacs for the quarter ended September 30, 2026 (Q2 FY27).
How did Ambar Protein Industries' Q2 FY27 net profit compare to Q2 FY26?
The net profit for Q2 FY27 was Rs. 219.91 Lacs, marking a 56.95% decrease from Rs. 510.76 Lacs reported in Q2 FY26.
What was the revenue from operations for Ambar Protein Industries in Q2 FY27?
Revenue from operations for Ambar Protein Industries in Q2 FY27 was Rs. 11,883.82 Lacs.
What is Ambar Protein Industries' basic EPS for Q2 FY27?
The Basic Earnings Per Share (EPS) for Ambar Protein Industries in Q2 FY27 was Rs. 3.83.

Questions based on this BSE filing only. For information purposes.

📑 More from Ambar Protein Industries Ltd

All BSE filings we have analysed for Ambar Protein Industries Ltd.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.